---
title: "HSN Code for Antibacterial Formulations | HSN 30049087 GST Rate"
description: "Find HSN and GST Rates for 30049087 related to Antibacterial Formulations with BUSY Accounting - The reliable source for HSN and GST details in India."
canonical: "https://busy.in/hsn/hsn-30049087/"
---

# HSN Code 30049087: Antibacterial Formulations

- [Section 06: Guide to HSN Section 06](https://busy.in/hsn/section-06/)
- [Chapter 30: Pharmaceutical Products](https://busy.in/hsn/chapter-30/)
- [Sub-chapter 3004: Medicaments for therapeutic uses](https://busy.in/hsn/sub-chapter-3004/)

## GST rates

| Description | CGST | SGST | IGST | CESS |
| --- | --- | --- | --- | --- |
| Other : Antiepiliptic drugs; sulfa drugs not elsewhere specified or included, preparations of enzymes; veterinary medicinal preparations, not for human use, not elsewhere specified or included; oral rehydration salts; antibacterial formulations not elsewhere specified or included, sedatives and tranquilizers : Antibacterial formulations, not elsewhere specified or included | 6% | 6% | 12% | 0% |

## Frequently asked questions

### What products are classified under HSN 30049087 ?

It includes Antibacterial Formulations

### Any common misclassification issue with Antibacterial Formulations?

Use the exact HSN and describe the form/grade. For multi‑line invoices, apply the rate per line to avoid wrong tax collection.

### How should mixed supplies be billed when Antibacterial Formulations is sold with other items?

Use separate invoice lines per HSN and apply the correct rate per line (e.g., Varies for Antibacterial Formulations; Nil for exempt items if applicable).

### How much GST applies to Antibacterial Formulations?

Under HSN 30049087, Antibacterial Formulations attracts Varies when sold in taxable form. Describe the exact form on the invoice.

### Can we claim ITC on inputs used to trade Antibacterial Formulations?

If your outward supply is taxable, eligible ITC is available subject to general restrictions. For exempt/Nil supplies, reverse credit per Rule 42.

### Do e‑way bill and e‑invoice apply for Antibacterial Formulations?

e‑Way bill is needed above ₹50,000 consignment value (subject to exemptions). e‑Invoicing is turnover‑based (presently AATO > ₹5 crore) for B2B supplies.

## India's trade performance: HSN Code 30049087 (FY 2024-25)

Source: TradeStat EIDB, Ministry of Commerce & Industry. Values in ₹ Crore (FY 2018-19 to FY 2024-25).

- Exports: ₹1,024 Cr (−2.78% YoY) — 0.0278% of India's total exports
- Imports: ₹2 Cr (−64.22% YoY) — 0.0000% of India's total imports
- Trade balance: ₹1,022 Cr (Surplus); surplus rank #348 of 12657 HSN codes
- Share of Sub-Chapter 3004: 0.55% of its exports; import side 0.02%
- Rank within Sub-Chapter 3004: #24 of 149 by export value; import-side #38

### Key metrics

- Export CAGR: 9.42% (FY 2018-19 to FY 2024-25, 7 fiscal years)
- National export rank: #510 of 12657 HSN codes by export value (FY 2024-25)
- Peak growth year: +37.79% in FY 2019-20
- Contribution to Sub-Ch. 3004: 0.55% of its exports (FY 2024-25)

## India export-import trade statistics: HSN Code 30049087

7-year export and import data, FY 2018-19 to FY 2024-25, in ₹ Crore. Source: Ministry of Commerce & Industry, TradeStat EIDB.

| FY | Exports (₹ Cr) | Exp share | Exp YoY | Exp % of Sub-Ch. 3004 | Imports (₹ Cr) | Imp share | Imp YoY | Imp % of Sub-Ch. 3004 | Trade balance | Exp rank |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| FY 2018-19 | 596.57 | 0.0261% | — | 0.64% | 2.12 | 0.0001% | — | 0.03% | +594.45 | #548 |
| FY 2019-20 | 822.04 | 0.0373% | +37.79% | 0.79% | 1.10 | 0.0000% | −48.11% | 0.01% | +820.94 | #405 |
| FY 2020-21 | 950.40 | 0.0442% | +15.61% | 0.74% | 2.27 | 0.0001% | +106.36% | 0.03% | +948.13 | #378 |
| FY 2021-22 | 901.37 | 0.0287% | −5.16% | 0.71% | 9.17 | 0.0002% | +303.96% | 0.07% | +892.20 | #504 |
| FY 2022-23 | 1,062.09 | 0.0293% | +17.83% | 0.75% | 2.28 | 0.0000% | −75.14% | 0.02% | +1,059.81 | #476 |
| FY 2023-24 | 1,053.26 | 0.0291% | −0.83% | 0.65% | 6.40 | 0.0001% | +180.70% | 0.07% | +1,046.86 | #492 |
| FY 2024-25 | 1,024.03 | 0.0278% | −2.78% | 0.55% | 2.29 | 0.0000% | −64.22% | 0.02% | +1,021.74 | #510 |

- CAGR (7-year): exports 9.42%/yr, imports 1.29%/yr (consistently Surplus)

## Key trade insights: HSN Code 30049087 export-import analysis

### Consistent export growth: 9.42% CAGR over 7 years

India's exports under HSN Code 30049087 have grown at a compound annual rate of 9.42% over 7 fiscal years, rising from ₹596.57 Crore in FY 2018-19 to ₹1,024.03 Crore in FY 2024-25.

### HSN Code 30049087 ranked #510 among all 12657 HSN codes by export value

In FY 2024-25, HSN Code 30049087 ranks #510 out of 12657 HSN codes by total export value. Within Sub-Chapter 3004, it ranks #24 of 149. By trade surplus, it ranks #348 of 12657.

### FY 2019-20 was the strongest growth year for HSN Code 30049087 exports

The strongest single-year export movement for HSN Code 30049087 was recorded in FY 2019-20, when exports surged by 37.79% over the prior year.

### India maintains a trade surplus of ₹1,021.74 Crore in HSN Code 30049087 goods

In FY 2024-25, India's exports of ₹1,024.03 Cr exceeded imports of ₹2.29 Cr, resulting in a trade surplus of ₹1,021.74 Crore — ranking #348 of 12657 by surplus magnitude.

### Import growth of 1.29% CAGR signals stable import dependency for Antibacterial Formulations

India's imports under HSN Code 30049087 have grown at 1.29% CAGR, reaching ₹2.29 Crore in FY 2024-25.

### HSN Code 30049087 contributes 0.55% of Sub-Chapter 3004 exports — ranked #24

Among the 149 HSN codes under Sub-Chapter 3004, HSN Code 30049087 ranks #24 by export value — accounting for 0.55% of the sub-chapter's total exports in FY 2024-25. On the import side, it holds 0.02% share (rank #38).

## Related HSN Codes in Sub-Chapter 3004

Ranked by export value (FY 2024-25).

| Rank | HSN Code | Exports (FY 2024-25) |
| --- | --- | --- |
| #1 | [HSN Code 30049099: Other therapeutic or prophylactic use products](https://busy.in/hsn/hsn-30049099/) | ₹82,761 Cr |
| #2 | [HSN Code 30049049: Other \| Anticancer Drugs](https://busy.in/hsn/hsn-30049049/) | ₹19,872 Cr |
| #3 | [HSN Code 30049079: Other \| Antihypertensive Drugs](https://busy.in/hsn/hsn-30049079/) | ₹9,153 Cr |
| #4 | [HSN Code 30049069: Nonsteroidal Analgesics & Antipyretics: Other Medicaments](https://busy.in/hsn/hsn-30049069/) | ₹7,577 Cr |
| #5 | [HSN Code 30049039: Other Antihistaminics/Antacids/Antiulcer/Antiemetics](https://busy.in/hsn/hsn-30049039/) | ₹5,465 Cr |
| #6 | [HSN Code 30041090: Other Penicillins or Streptomycins](https://busy.in/hsn/hsn-30041090/) | ₹3,685 Cr |
| #7 | [HSN Code 30042019: Other Cephalosporin Antibiotics](https://busy.in/hsn/hsn-30042019/) | ₹3,036 Cr |
| #8 | [HSN Code 30049081: Antiepileptic & Sulfa Drugs](https://busy.in/hsn/hsn-30049081/) | ₹2,870 Cr |
| #9 | [HSN Code 30049082: Other Antiepileptic Drugs](https://busy.in/hsn/hsn-30049082/) | ₹2,860 Cr |
| #10 | [HSN Code 30049029: Other Anthelmintic/Antiamoebic/Antifungal Drugs](https://busy.in/hsn/hsn-30049029/) | ₹2,697 Cr |
| #24 | HSN Code 30049087: Antibacterial Formulations (this hsn code) | ₹1,024 Cr |